Slomovitz B - Search Results

1

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.

Gershenson DM, Miller A, Brady WE, Paul J, Carty K, Rodgers W, Millan D, Coleman RL, Moore KN, Banerjee S, Connolly K, Secord AA, O'Malley DM, Dorigo O, Gaillard S, Gabra H, Slomovitz B, Hanjani P, Farley J, Churchman M, Ewing A, Hollis RL, Herrington CS, Huang HQ, Wenzel L, Gourley C. Gershenson DM, et al. Among authors: slomovitz b. Lancet. 2022 Feb 5;399(10324):541-553. doi: 10.1016/S0140-6736(21)02175-9. Lancet. 2022. PMID: 35123694 Free PMC article. Clinical Trial.

2

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

3

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.

Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Slomovitz BM, et al. J Clin Oncol. 2004 Aug 1;22(15):3126-32. doi: 10.1200/JCO.2004.11.154. J Clin Oncol. 2004. PMID: 15284264

4

Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.

Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Soliman PT, et al. Gynecol Oncol. 2004 Aug;94(2):456-62. doi: 10.1016/j.ygyno.2004.05.006. Gynecol Oncol. 2004. PMID: 15297188 Review.

5

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

6

Risk factors for young premenopausal women with endometrial cancer.

Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Soliman PT, et al. Obstet Gynecol. 2005 Mar;105(3):575-80. doi: 10.1097/01.AOG.0000154151.14516.f7. Obstet Gynecol. 2005. PMID: 15738027

7

Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy.

Slomovitz BM, Ramondetta LM, Lee CM, Oh JC, Eifel PJ, Jhingran A, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Int J Gynecol Cancer. 2005 May-Jun;15(3):510-6. doi: 10.1111/j.1525-1438.2005.15317.x. Int J Gynecol Cancer. 2005. PMID: 15882178 Free article.

8

Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas.

Caudell JJ, Deavers MT, Slomovitz BM, Lu KH, Broaddus RR, Gershenson DM, Ramondetta LM. Caudell JJ, et al. Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):167-70. doi: 10.1097/01.pai.0000129057.38941.a1. Appl Immunohistochem Mol Morphol. 2005. PMID: 15894930

9

Endometrial cancer in young, normal-weight women.

Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Schmeler KM, et al. Gynecol Oncol. 2005 Nov;99(2):388-92. doi: 10.1016/j.ygyno.2005.06.029. Epub 2005 Jul 26. Gynecol Oncol. 2005. PMID: 16051336

10

Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?

Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH. Soliman PT, et al. J Clin Oncol. 2005 Dec 20;23(36):9344-50. doi: 10.1200/JCO.2005.03.5915. J Clin Oncol. 2005. PMID: 16361634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters